#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14664	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2620	690.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1946	1946	T	927	T,C	926,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14664	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2620	690.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1680	1680	C	938	C,T,A	936,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4059	750.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1959	1959	A	1032	A,C,G	1029,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4059	750.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2593	2593	C	773	C,T	771,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4059	750.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3219	3219	T	824	T,C,G	822,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24436	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4059	750.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2667	2667	A	744	A,C	741,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	G5V	NONSYN	13	15	GGT	503	505	GTT	120;119;118	G;T;T	120;119;118	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	E12K	NONSYN	34	36	GAA	524	526	AAA	130;132;132	A,G;A;A	129,1;132;132	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	F31L	NONSYN	91	93	TTT	581	583	TTG	159;159;159	T;T,G;G,T,A	159;158,1;157,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	614	616	CAA	178;178;178	C;A;A	178;178;178	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	S75P	NONSYN	223	225	TCC	713	715	CCT	180;182;183	C,A;C;T	179,1;182;183	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	V87A	NONSYN	259	261	GTA	749	751	GCA	159;158;156	G;C;A	159;158;156	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	V130L	NONSYN	388	390	GTC	878	880	CTC	190;194;192	C;T;C,T	190;194;191,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	R135C	NONSYN	403	405	CGC	893	895	TGT	204;207;207	T;G;T,A	204;207;206,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	T137A	NONSYN	409	411	ACG	899	901	GCG	218;216;214	G;C,T;G	218;215,1;214	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	941	943	AAG	234;232;233	A,G,T;A;G,A,T,C	232,1,1;232;230,1,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	944	946	AAT	235;235;236	A,T;A,C,G;T,C,G	234,1;233,1,1;233,2,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1142	1144	TTG	119;118;118	T;T,G;G	119;117,1;118	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1172	1174	AGC	122;124;123	A;G;C	122;124;123	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1241	1243	CTG	131;130;129	C;T;G	131;130;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1247	1249	TCC	123;123;121	T,G,A;C;C,T,A	121,1,1;123;119,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1262	1264	GTG	142;142;142	G;T;G	142;142;142	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1628	folP	852	852	93.78	folP.l15.c4.ctg.1	1881	107.4	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1313	1315	GCG	159;159;160	G,C;C;G,C	158,1;159;159,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5382	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3769	177.9	1	SNP	p	S91F	0	.	.	271	273	TCC	777	779	TCC	188;191;193	T,G;C;C	187,1;191;193	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5382	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3769	177.9	1	SNP	p	D95N	0	.	.	283	285	GAC	789	791	GAC	199;200;202	G;A;C,A	199;200;201,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5382	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3769	177.9	1	SNP	p	D95G	0	.	.	283	285	GAC	789	791	GAC	199;200;202	G;A;C,A	199;200;201,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	2042	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1810	140.7	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	991	991	T	223	T	223	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1248	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1504	103.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1723	1725	ATC	225;224;226	A;T,A;C	225;223,1;226	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1876	1878	GCA	204;206;210	G,T;C,A;A,C	203,1;205,1;209,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	1	SNP	p	D86N	0	.	.	256	258	GAC	829	831	GAC	221;219;216	G,A;A;C	218,3;219;216	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	1	SNP	p	S87W	0	.	.	259	261	AGT	832	834	AGT	215;214;216	A;G;T	215;214;216	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	1	SNP	p	S87I	0	.	.	259	261	AGT	832	834	AGT	215;214;216	A;G;T	215;214;216	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	1	SNP	p	S87R	0	.	.	259	261	AGT	832	834	AGT	215;214;216	A;G;T	215;214;216	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4808	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3443	174.2	1	SNP	p	S88P	0	.	.	262	264	TCC	835	837	TCC	217;217;220	T,A;C;C	216,1;217;220	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4244	parE	1986	1986	99.95	parE.l15.c17.ctg.1	3030	174.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1712	1714	GGC	228;228;230	G,T;G;C	227,1;228;230	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1422	1424	GCA	234;232;232	G,T;C;A	233,1;232;232	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1425	1427	ATC	231;226;228	A;T,G;C	231;225,1;228	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1437	1439	GTG	231;231;233	G;T,C;G	231;230,1;233	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1437	1439	GTG	231;231;233	G;T,C;G	231;230,1;233	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1941	1943	ACC	213;215;212	A;C;C	213;215;212	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1995	1997	GCG	208;206;208	G;C;G	208;206;208	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1995	1997	GCG	208;206;208	G;C;G	208;206;208	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2118	2120	GGT	204;205;207	G,T;G;T	203,1;205;207	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2127	2129	GGC	209;210;210	G;G;C	209;210;210	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3924	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2734	178.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2145	2147	CCG	203;206;208	C,G;C,A;G,C	202,1;205,1;207,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5560	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3554	195.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2456	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2331	131.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	630	632	GGC	157;155;157	G;G;C	157;155;157	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2456	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2331	131.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	812	812	C	208	C,G	207,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	33;36;37	T,G;T;A	32,1;36;37	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	68;68;68	C;A;T	68;68;68	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	68;68;68	A;G;T	68;68;68	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	68;68;68	T;A;C	68;68;68	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	3;3;3	G;A;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;5;5	G;C;C	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	318	35.4	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.1	porB1b.l6.c17.ctg.1	2078	172.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1192	1192	T	217	T	217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.1	porB1b.l6.c17.ctg.1	2078	172.5	1	SNP	p	G120K	0	.	.	358	360	GGT	919	921	GGT	230;231;233	G;G;T	230;231;233	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.1	porB1b.l6.c17.ctg.1	2078	172.5	1	SNP	p	A121N	0	.	.	361	363	GCC	922	924	GCC	231;230;232	G;C,T;C,G	231;229,1;231,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2876	porB1b	1035	1035	98.1	porB1b.l6.c17.ctg.1	2078	172.5	1	SNP	p	A121D	0	.	.	361	363	GCC	922	924	GCC	231;230;232	G;C,T;C,G	231;229,1;231,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9858	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5342	230.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1490	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1563	118.9	1	SNP	p	V57M	1	.	.	169	171	ATG	774	776	ATG	250;254;255	A;T,G;G	250;253,1;255	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
